XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statement of Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interest in Consolidated Entities
Preferred Stock
Redeemable Noncontrolling Interests in Operating Partnership
Series B Preferred Stock
Series B Preferred Stock
Accumulated Deficit
Series B Preferred Stock
Preferred Stock
Series D Preferred Stock
Series D Preferred Stock
Accumulated Deficit
Series D Preferred Stock
Preferred Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
5.50% Series B cumulative convertible preferred stock, $0.01 par value, 4,965,850 shares issued and outstanding at March 31, 2019 and December 31, 2018                   $ 106,123      
Beginning balance (in shares) at Dec. 31, 2017   32,120               4,966     0
Beginning balance at Dec. 31, 2017 $ 376,552 $ 321 $ 469,791 $ (88,807) $ (4,753)               $ 0
Beginning balance at Dec. 31, 2017             $ 46,627            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Purchase of common stock (in shares)   (7)                      
Purchase of common stock (74)   (74)                    
Equity-based compensation 2,449   2,449       144            
Issuance of restricted shares/units (in shares)   406                      
Issuance of restricted shares/units 58 $ 4 54       18            
Forfeiture of restricted common shares (in shares)   (2)                      
Forfeiture of restricted common shares 0                        
Dividends declared – common stock (5,275)     (5,275)                  
Dividends declared – preferred stock 0             $ (1,707) $ (1,707)        
Distributions to noncontrolling interests 0           (822)            
Net income (loss) 4,020     4,020     292            
Net income (loss) 3,978       (42)                
Ending balance (in shares) at Mar. 31, 2018   32,517               4,966     0
Ending balance at Mar. 31, 2018 375,981 $ 325 472,220 (91,769) (4,795)               $ 0
Ending balance at Mar. 31, 2018             46,259            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Dividends declared per common share (in dollars per share)   $ 0.16       $ 0.34              
5.50% Series B cumulative convertible preferred stock, $0.01 par value, 4,965,850 shares issued and outstanding at March 31, 2019 and December 31, 2018                   $ 106,123      
Common stock, $0.01 par value, 200,000,000 shares authorized, 32,841,263 and 32,511,660 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively 325                        
Additional paid-in capital 512,545                        
Accumulated deficit (115,410)                        
5.50% Series B cumulative convertible preferred stock, $0.01 par value, 4,965,850 shares issued and outstanding at March 31, 2019 and December 31, 2018 106,123                 $ 106,123      
Beginning balance (in shares) at Dec. 31, 2018   32,512               4,966     1,600
Beginning balance at Dec. 31, 2018 392,085 $ 325 512,545 (115,410) (5,391)               $ 16
Beginning balance at Dec. 31, 2018 44,885           44,885            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Impact of adoption of new accounting standard [1] (103)     (103)                  
Purchase of common stock (in shares)   (17)                      
Purchase of common stock (202)   (202)                    
Equity-based compensation 978   978       550            
Preferred stock offering costs (13)   (13)                    
Issuance of restricted shares/units (in shares)   237                      
Issuance of restricted shares/units 0 $ 2 (2)       7            
Forfeiture of restricted common shares (in shares)   (1)                      
Forfeiture of restricted common shares 0                        
Dividends declared – common stock (5,329)     (5,329)                  
Dividends declared – preferred stock (825)             $ (1,707) $ (1,707)   $ (825) $ (825)  
Distributions to noncontrolling interests 0           (778)            
Redemption/conversion of operating partnership units   110                      
Redemption/conversion of operating partnership units 1,149 $ 1 1,433 (285)                  
Redemption/conversion of operating partnership units             (1,149)            
Net income (loss) (981)     (981)     (440)            
Net income (loss) (882)       99                
Redemption value adjustment (7,935)     (7,935)     7,935            
Ending balance (in shares) at Mar. 31, 2019   32,841               4,966     1,600
Ending balance at Mar. 31, 2019 377,216 $ 328 $ 514,739 $ (132,575) $ (5,292)               $ 16
Ending balance at Mar. 31, 2019 $ 51,010           $ 51,010            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Dividends declared per common share (in dollars per share) $ 0.52 $ 0.16                      
Common stock, $0.01 par value, 200,000,000 shares authorized, 32,841,263 and 32,511,660 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively $ 328                        
Additional paid-in capital 514,739                        
Accumulated deficit (132,575)                        
5.50% Series B cumulative convertible preferred stock, $0.01 par value, 4,965,850 shares issued and outstanding at March 31, 2019 and December 31, 2018 $ 106,123                 $ 106,123      
[1] see notes 2 and 5.